RPM INTERNATIONAL INC/DE/ (RPM)·Q1 2026 Earnings Summary
Executive Summary
- RPM delivered record Q1 FY26 revenue of $2.11B (+7.4% YoY), record adjusted EBIT of $337.8M (+2.9% YoY), and record adjusted EPS of $1.88, while GAAP diluted EPS held flat at $1.77; organic growth (+3.0%) was complemented by acquisitions (+3.8%) and FX (+0.6%) .
- Versus Wall Street: revenue beat consensus ($2.11B vs $2.05B, +2.9%), EPS was essentially in line ($1.88 vs $1.88), and EBITDA missed ($373.7M vs $395.8M); the company raised full-year sales outlook to the high end of prior range, and lowered adjusted EBIT outlook to the low end of prior range, shifting mix toward growth investments and price actions to offset tariffs . Consensus values marked with asterisks; Values retrieved from S&P Global.*
- Management cited tariff-driven cost inflation, higher healthcare costs (+$8M YoY), and temporary plant consolidation inefficiencies (~$10M in Q1) as profitability headwinds, while highlighting strong volumes in Construction and Performance Coatings from turnkey solutions and systems selling .
- Dividend increased 5.9% to $0.54 per share (52nd consecutive annual increase), providing yield support; leadership changes underpin segment streamlining from four to three groups, aimed at SG&A efficiency and collaboration .
What Went Well and What Went Wrong
What Went Well
- Record consolidated results: Net sales $2.11B (+7.4% YoY), adjusted EBIT $337.8M (+2.9% YoY), adjusted EPS $1.88 (+2.2% YoY); “…record adjusted EBIT in 14 out of the last 15 quarters.” .
- Segment strength: PCG net sales +9.9% and adjusted EBIT +11.0% YoY; CPG and Consumer also posted record sales, with systems/turnkey offerings and accretive acquisitions as key drivers .
- Geographic momentum: Europe +20.7% growth (acquisitions and FX) and North America +5.9% driven by high‑performance building solutions .
Quote: “We leveraged our ability to provide turnkey solutions and systems to high-performance buildings… The successful integration of strategic business acquisitions also played an important role in achieving record sales.” — Frank C. Sullivan .
What Went Wrong
- Profitability headwinds: Higher healthcare expense (+$8M YoY), tariff-related inflation, and temporary inefficiencies from six plant consolidations (~$10M unfavorable conversion/absorption) pressured leverage to the bottom line .
- Consumer softness: DIY demand remained challenged; Consumer organic sales declined 2.9% despite acquisitions; mix and lower fixed-cost utilization weighed on margins .
- Tariffs: Unmitigated tariff impact estimated at ~$90–95M with ~half mitigated via pricing, production shifts, and supplier cost sharing; Q1 price realization ~0.5%, expected ~2% in Q2 as actions flow through .
Financial Results
Consolidated Performance vs prior two quarters
Notes: Gross margin computed from gross profit/net sales using cited values .
Q1 2026 vs Estimates (S&P Global)
Consensus counts: EPS (14), Revenue (11). Values retrieved from S&P Global.*
Segment Breakdown – Q1 2026 vs Q1 2025
Mix: Q1 2026 sales growth comprised organic (+3.0%), acquisitions (+3.8%), FX (+0.6%) .
KPIs and Balance Sheet (Q1 2026)
Non-GAAP reconciliation drivers in Q1: MAP initiatives ($0.10 EPS), inventory step-up costs ($0.04 EPS), investment returns (-$0.03 EPS) .
Margin Detail (Q1 2026)
Computed using EBIT/Net Sales (cited values) .
Guidance Changes
Rationale: Price increases late in Q1 to mitigate tariffs, SG&A streamlining from 4 to 3 segment reorg, continued growth investments to accelerate pivot to growth .
Earnings Call Themes & Trends
Management Commentary
- “Adjusted EBIT was a record… more than offset the impact of SG&A growth investments, higher healthcare expenses and increased inflation.” — Frank C. Sullivan .
- “We expect… record sales and adjusted EBIT in both the second quarter and for the full fiscal year.” — Management Outlook .
- “During the first quarter, there was about $10 million of unfavorable… conversion costs and unfavorable absorption that occurred.” — Rusty (CFO) on plant consolidations .
- “Total unmitigated impact of tariffs… about $90 million or $95 million… we have effectively offset about half.” — Frank C. Sullivan .
- “Price in the quarter was about 0.5%… somewhat higher in Q2.” — Frank C. Sullivan .
Q&A Highlights
- Profitability headwinds: Healthcare costs +$8M YoY (partly persistent due to weight-loss drug coverage), ~$10M consolidation inefficiency, deliberate ~$10M growth investment in sales/advertising/M&A .
- Tariffs & price realization: ~$90–95M unmitigated; ~50% mitigated via pricing, supplier cost-sharing, and production shifts (e.g., The Pink Stuff to US); Q2 inflation expected 2–3% consolidated; Consumer most impacted (metal packaging) .
- Segment demand & backlog: Strong reroofing/institutional projects; HVAC refurbishment (Purera) scaling; One Tremco approach expanding spec wins; PCG gaining larger OEM accounts (e.g., first project with John Deere) .
- Consumer pivots: New channels (grocery, dollar), expanded cleaners portfolio (The Pink Stuff + Rust‑Oleum brands), increased digital/social advertising .
- Capital structure/M&A: ~$600M acquisitions over five months (Consumer), debt/EBITDA ~1.8x, PE less active; deal multiples down 2–3 turns vs peak .
Estimates Context
- Revenue beat: $2.11B actual vs $2.05B consensus (+2.9%) — positive top-line surprise likely supported by systems/turnkey solutions and acquisition contributions . Consensus revenue marked with asterisk; Values retrieved from S&P Global.*
- EPS in line: $1.88 adjusted EPS actual vs $1.88023 consensus — neutral; higher interest expense from acquisition financing offset EBIT gains . Consensus EPS marked with asterisk; Values retrieved from S&P Global.*
- EBITDA miss: $373.7M actual vs $395.8M consensus (-5.6%) — reflects tariff inflation, higher healthcare costs, and consolidation inefficiencies dampening margin conversion . Consensus EBITDA marked with asterisk; Values retrieved from S&P Global.*
Key Takeaways for Investors
- Top-line strength with systems/turnkey offerings and acquired brands drove a revenue beat; the pivot to growth (sales force expansion, advertising) is working, but it lowers near-term operating leverage .
- Expect Q2 mid-single-digit sales and adjusted EBIT growth with incremental pricing to offset tariffs; watch Consumer price pass-through and packaging inflation trajectory as key swing factors .
- Margin trajectory should improve as plant consolidation inefficiencies roll off; current ~$10M quarterly headwind likely persists into Q2 then fades — a catalyst for EBITDA normalization .
- The raised full-year sales outlook vs lowered adjusted EBIT outlook signals mix toward growth investments; re-rating hinges on proof that SG&A redeployment drives sustainable share gains, especially in Consumer .
- Dividend increase (to $0.54) and ~1.8x leverage provide defensive attributes amid investment phase; capital deployment focused on adjacencies (cleaning, exterior wood) and high-spec building systems .
- Monitor tariff policy and pricing cadence: consolidated pricing ~0.5% in Q1 rising to ~2% in Q2; stronger realization would underpin margin resilience into FY26 .
- Near-term trading: stock sensitive to Q2 margins and pricing narrative; medium-term thesis rests on systems selling, MAP-enabled efficiencies, and consumer channel expansion offsetting macro uncertainty .